Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)	8 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2024
Cash Flows from Operating Activities:
Net income (loss)	$ (385,705)	$ 102,737
Adjustments to reconcile net income (loss) to net cash and cash equivalents used in operating activities:
Change in fair value of derivative warrant liabilities		(357,080)
Changes in operating assets and liabilities:
Prepaid expenses and other receivables	(708)	(104,600)
Deposit		(144,000)
Accounts payable and accrued expenses	289,698	(970,377)
Deferred revenue		207,436
Net cash and cash equivalents used in operating activities	(96,715)	(1,265,884)
Cash Flows from Financing Activities:
Capital contribution from Members	12,500
Proceeds from promissory note – related party	83,950
Advances – related party	792
Proceeds from forward purchase agreement		275,000
Net cash and cash equivalents provided by financing activities	97,242	275,000
Net change in cash and cash equivalents	527	(990,884)
Cash and cash equivalents, beginning of period		1,183,328
Cash and cash equivalents, end of period	527	192,444
Supplemental Cash flow information:
Taxes paid